The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
NCT: NCT05446272 · RECRUITING
Brief Summary
DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 23 0/7-28 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure within (T) 5 days (120 hours) of extubation.
Frequently Asked Questions
What is The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial?
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial is a clinical trial registered under NCT05446272. Current status: RECRUITING.
What is the status of NCT05446272?
The current status of NCT05446272 (The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial) is: RECRUITING.
When did The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial start?
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial started on 2022-08-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.